|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: John O'Quigley (University of Pierre and Marie Curie, Paris, France) , Alexia Iasonos (Memorial Sloan Kettering Cancer Center, New York, USA) , Björn Bornkamp (Novartis Pharma AG, Basel, Switzerland)Publisher: Taylor & Francis Ltd Imprint: Chapman & Hall/CRC Weight: 0.562kg ISBN: 9780367330682ISBN 10: 0367330687 Pages: 320 Publication Date: 08 August 2019 Audience: College/higher education , General/trade , Tertiary & Higher Education , General Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsThis book provides different perspectives for revisiting drug development in both therapeutic areas. Statisticians involved in earlyphase clinical trials, whether in academia or in industry, may get benefit from this book. They will find descriptions of some innovative methods that will be helpful in designing dose-finding trials. ~Xavier Paoletti, Biometric Journal """This book provides different perspectives for revisiting drug development in both therapeutic areas. Statisticians involved in earlyphase clinical trials, whether in academia or in industry, may get benefit from this book. They will find descriptions of some innovative methods that will be helpful in designing dose-finding trials."" ~Xavier Paoletti, Biometric Journal" This book provides different perspectives for revisiting drug development in both therapeutic areas. Statisticians involved in early phase clinical trials, whether in academia or in industry, may get benefit from this book. They will find descriptions of some innovative methods that will be helpful in designing dose-finding trials. ~Xavier Paoletti, Biometric Journal Author InformationO'Quigley, John; Iasonos, Alexia; Bornkamp, Björn Tab Content 6Author Website:Countries AvailableAll regions |